PSMA-1007

Cat. No. M52838

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.

PSMA-1007 is a prostate-specific membrane antigen (PSMA) ligand.

Molecular Weight	1184.13
Formula	C54H64F3N9O18
CAS Number	2226894-58-0
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related PSMA Products
Vipivotide tetraxetan Vipivotide tetraxetan (PSMA-617) is a potent prostate-specific membrane antigen (PSMA) inhibitor with Ki value of 0.37 nM, it is used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer.
PSMA-11 Psma-11 is a positron emission tomography (PET) tracer. Psma-11 detects recurrence and metastasis of prostate cancer by binding to the extracellular region of prostate specific membrane antigen (PSMA). Sequence: Glu - NH - CO - NH - Lys (Ahx) - HBED - CC
Pasotuxizumab Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC).
Rosopatamab Rosopatamab (HJ 591) is a humanised anti-PSMA monoclonal antibody that can be used in cancer research, particularly in prostate cancer.
Pelgifatamab Pelgifatamab is a monoclonal antibody targeting prostate cancer-specific membrane antigen (PSMA) for prostate cancer-related studies.

Catalog